In this episode we’ll talk more about what hides behind the structures of our brain, in the core of the thalamus. Thalamic atrophy measurements have existed for a long time, but within MS it is quite new to look into the thalamic atrophy, also as a biomarker. Today’s guest, Prof. Dr. Cristina Granziera, will tell us more about how knowledge about thalamic atrophy can be implemented in clinical practice.

GZNO.MS.19.11.0310
MAT-GLB-2003396-v1.0

A promising biomarker in MS: Neurofilament light chain

In Sanofi's podcast “The MS Podcast”, the focus is on Multiple Sclerosis and brain health. Through the different episodes we talk to various specialists within neuroscience, psychology  and physical activity to help shed light on the many aspects of treating MS. Tune in and learn more!